Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEROTRALSTAT vs LANADELUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEROTRALSTAT vs LANADELUMAB: Safety Overview

Metric BEROTRALSTAT LANADELUMAB
Total FAERS Reports 548 2,058
Deaths Reported 24 109
Death Rate 4.4% 5.3%
Hospitalizations 128 1,007
Average Patient Age 45.9 yrs 47.3 yrs
% Female Patients 74.7% 75.7%
FDA Approval Date Dec 11, 2025 N/A
Manufacturer BioCryst Pharmaceuticals, Inc. Takeda Pharmaceuticals America, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription N/A